Selected article for: "factor study and prognostic factor study"
Title: RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS
  • Document date: 2018_12_19
    • ID: r79h9yzz_520
    Snippet: Insulinoma is the most common canine pancreatic tumour and is likely to metastasise to regional lymph nodes, liver and lungs. Surgery is currently the preferred treatment for insulinoma, with dogs treated surgically surviving significantly longer than those treated conservatively (median survival 381 days versus 74 days). Prognostic factors for insulinoma are poorly‐described. In one study, postoperative hypoglycaemia was a negative prognostic .....
    Document: Insulinoma is the most common canine pancreatic tumour and is likely to metastasise to regional lymph nodes, liver and lungs. Surgery is currently the preferred treatment for insulinoma, with dogs treated surgically surviving significantly longer than those treated conservatively (median survival 381 days versus 74 days). Prognostic factors for insulinoma are poorly‐described. In one study, postoperative hypoglycaemia was a negative prognostic factor, however significance of other factors such as postoperative complications is currently unknown.

    Search related documents:
    Co phrase search for related documents
    • lung liver and median survival: 1, 2, 3, 4, 5
    • lung liver and preferred treatment: 1
    • lymph node and median survival: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • lymph node and negative prognostic factor: 1
    • lymph node and pancreatic tumour: 1
    • lymph node and postoperative complication: 1, 2, 3, 4, 5, 6, 7, 8
    • lymph node and preferred treatment: 1
    • lymph node and prognostic factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • lymph node and regional lymph node: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • median survival and negative prognostic factor: 1
    • median survival and postoperative complication: 1, 2, 3, 4, 5
    • median survival and preferred treatment: 1, 2
    • median survival and prognostic factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • median survival and regional lymph node: 1
    • negative prognostic factor and prognostic factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
    • postoperative complication and preferred treatment: 1
    • postoperative complication and prognostic factor: 1
    • postoperative complication factor and prognostic factor: 1